Explanatory and pragmatic estimates of the treatment effect when deviations from allocated treatment occur
- 1 November 1988
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 7 (11) , 1179-1186
- https://doi.org/10.1002/sim.4780071111
Abstract
In a randomized clinical trial comparing two treatments it can happen that certain patients receive the treatment other than that determined by random allocation. Significance testing is usually performed by ‘intention to treat’, that is, comparison of groups as determined by random allocation. The difference between the mean values of the outcome variable for these two groups estimates the difference in practical use between two treatment policies, corresponding to a pragmatic approach. An attenuation factor can then be used to obtain an estimate of the underlying difference in effectiveness between the two treatments, corresponding to an explanatory paradigm. Thus two distinct estimates are obtained; in many instances both are valid, but have distinct interpretations. Correspondingly, in planning sample size requirements when deviations from allocated treatment can be anticipated, the target treatment difference may be understood in either an explanatory or a pragmatic sense; for the sample size assessment method it is necessary to take this distinction into account.Keywords
This publication has 8 references indexed in Scilit:
- Explanatory and pragmatic attitudes in therapeutical trialsPublished by Elsevier ,2004
- On the Mathematical Basis of Zelen’s Prerandomized DesignsMethods of Information in Medicine, 1985
- The Relative Efficiency of Zelen's Prerandomization Design for Clinical TrialsPublished by JSTOR ,1983
- Alternatives to Classic Randomized TrialsSurgical Clinics of North America, 1981
- Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.BMJ, 1980
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976